title: In vivo evaluation of porous silicon and porous silicon solid lipid nanocomposites for passive targeting and imaging.
abstract: The use of nanoparticle carriers for the sustained release of cytotoxic drugs in cancer therapy can result in fewer adverse effects and can thus be of great benefit for the patient. Recently, a novel nanocomposite, prepared by the encapsulation of THCPSi nanoparticles within solid lipids (SLN), was developed and characterized as a promising drug delivery carrier in vitro. The present study describes the in vivo evaluation of unmodified THCPSi nanoparticles and THCPSi-solid lipid nanocomposites (THCPSi-SLNCs) as potential drug delivery carriers for cancer therapy by using (18)F radiolabeling for the detection of the particle biodistribution in mice. Passive tumor targeting of (18)F-THCPSis and (18)F-THCPSi-SLNCs by the enhanced permeation and retention effect was investigated in a murine breast cancer model. Encapsulation of THCPSi nanoparticles with solid lipids improved their accumulation in tumors at a 7 week time point (tumor-to-liver ratio 0.10 ± 0.08 and 0.24 ± 0.09% for (18)F-THCPSis and (18)F-THCPSi-SLNCs, respectively).
authors: Laboratory of Radiochemistry, Department of Chemistry, University of Helsinki , FI-00014 Helsinki, Finland.
authors: Annukka M
authors: AM
authors: Kallinen
authors: Mirkka P
authors: MP
authors: Sarparanta
authors: Dongfei
authors: D
authors: Liu
authors: Ermei M
authors: EM
authors: Mäkilä
authors: Jarno J
authors: JJ
authors: Salonen
authors: Jouni T
authors: JT
authors: Hirvonen
authors: Hélder A
authors: HA
authors: Santos
authors: Anu J
authors: AJ
authors: Airaksinen
mesh_terms: D000818:Animals; D001345:Autoradiography; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D004337:Drug Carriers; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008055:Lipids / Q000737:chemistry*; D008099:Liver / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D046529:Microscopy, Electron, Transmission; D053761:Nanocomposites / Q000737:chemistry*; D053758:Nanoparticles; D036103:Nanotechnology / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy; D016062:Porosity; D012710:Serum Albumin, Bovine / Q000737:chemistry; D012825:Silicon / Q000737:chemistry*; D013997:Time Factors; D014018:Tissue Distribution
chemical_list: D004337:Drug Carriers; D008055:Lipids; D012710:Serum Albumin, Bovine; D012825:Silicon